Medicare Enrolled

Dr. Aaron Spitz, M.D.

Optician · Laguna Hills, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
23961 CALLE DE LA MAGDALENA STE 500, Laguna Hills, CA 92653
9498551101
In practice since 2006 (19 years)
NPI: 1164487674 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Spitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Spitz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Spitz

Dr. Aaron Spitz is an optician specialist in Laguna Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Spitz performed 2,876 Medicare services across 1,933 unique beneficiaries.

Between the years covered by Open Payments, Dr. Spitz received a total of $98,799 from 23 pharmaceutical and/or device companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Spitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 29% volume in CA $98,799 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,876
Medicare services
Top 29% in CA for optician
1,933
Unique beneficiaries
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~151 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
638 $2 $6
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
563 $9 $38
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
434 $67 $297
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
397 $101 $420
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
129 $20 $84
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
104 $129 $542
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
70 $68 $253
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
63 $13 $48
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
60 $0 $1
Injection to correct thickened penile tissue
An injection procedure used to treat thickened tissue in the penis.
59 $99 $391
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
49 $24 $338
Bladder irrigation and/or instillation
This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder.
48 $67 $260
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
48 $45 $188
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
47 $207 $832
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
39 $149 $561
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
28 $95 $377
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
25 $53 $196
Transrectal ultrasound of prostate
An ultrasound imaging procedure where a probe is inserted into the rectum to create pictures of the prostate gland.
20 $162 $599
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
15 $129 $710
Prostate needle biopsy pathology exam
Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities.
15 $179 $665
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
14 $219 $813
3D radiographic procedure with computerized image postprocessing
A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data.
11 $70 $258
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$98,799
Total received (2018-2024)
Avg $14,114/year across 7 years
Top 3% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
100
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$87,074 (88.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$9,655 (9.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,069 (2.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$375
2023
$352
2022
$809
2021
$6,634
2020
$18
2019
$28,542
2018
$62,069

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
HISTOSONICS,INC.
$148
ABBVIE INC.
$77
Antares Pharma, Inc.
$38
Astellas Pharma US Inc
$32
Janssen Biotech, Inc.
$30
ACCORD HEALTHCARE, INC.
$25
Endo USA, Inc.
$25
Top 3 companies account for 70.0% of 2024 payments
All-time payments by company (2018-2024) ›
Endo Pharmaceuticals Inc.
$80,777
AbbVie, Inc.
$7,101
AbbVie Inc.
$6,413
Metuchen Pharmaceuticals
$2,665
Teleflex LLC
$273
PROCEPT BioRobotics Corporation
$251
Medtronic, Inc.
$240
ABBVIE INC.
$201
Astellas Pharma US Inc
$194
HISTOSONICS,INC.
$148
Myovant Sciences Inc.
$100
Janssen Biotech, Inc.
$74
Progenics Pharmaceuticals, Inc.
$61
Antares Pharma, Inc.
$51
Boston Scientific Corporation
$45
BOSTON SCIENTIFIC CORPORATION
$30
Olympus America Inc.
$28
Tolmar, Inc.
$28
UroGen Pharma, Inc.
$27
ACCORD HEALTHCARE, INC.
$25
Endo USA, Inc.
$25
Bayer Healthcare Pharmaceuticals Inc.
$23
UROVANT SCIENCES INC
$19
Top 3 companies account for 95.4% of all-time payments
Associated products mentioned in payments ›
ALLODERM · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · BOTOX · CAMCEVI · CYSTO-NEPHRO VIDEOSCOPE · ELIGARD · ERLEADA · Erleada · GEMTESA · INTERSTIM · JELMYTO · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Nubeqa · ORGOVYX · REZUM · Rezum Generator · Stendra · UROLIFT · UroLift 2 System · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for optician in CA.

Looking for an optician specialist in Laguna Hills?
Compare opticians in the Laguna Hills area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
606
Per 100K population
19.2
County median income
$113,702
Nearest hospital
MEMORIALCARE SADDLEBACK MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Spitz is a clinical cardiology specialist, with above-average Medicare volume (top 29% in CA), with consulting-driven industry engagement in the top 3% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Spitz experienced with automated urinalysis?
Based on Medicare claims data, Dr. Spitz performed 638 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Spitz receive payments from pharmaceutical companies?
Yes. Dr. Spitz received a total of $98,799 from 23 companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Spitz's costs compare to other opticians in Laguna Hills?
Dr. Spitz's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Spitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →